Researchers suggest an application to FDA may be made within the next 12 months, requesting approval to carry out a human clinical trial with the gene therapy.

A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model. The therapy ...

New research suggests that consuming sugar-sweetened drinks may raise your risk of cardiovascular disease, while eating the ...

The following is a summary of “Optimising the treatment of chronic ischemic heart disease by training general practitioners to deliver very brief advice on physical activity (OptiCor): protocol of the ...

Drinking sweetened beverages can increase cardiovascular disease risk, but occasionally savoring sugary refreshments doesn't ...

New research in B.C. is showing an increased need for health-care professionals to talk to patients with chronic conditions.

We appreciate FDA’s support in designating REVASCOR both RMAT and RPD status, a recognition of the potential impact of our therapy on the long-term adverse outcomes of these desperately ill children.

In China, stroke and ischaemic heart disease led to 286 deaths per 100 000 persons in 2019, already above the worldwide average, with a continuous upward trend since 1990, which became one of the most ...

Detailed price information for Koninklijke Philips Electronics ADR (PHG-N) from The Globe and Mail including charting and trades.

Phase 3 trial results published in European Journal of Heart Failure identify key target population for Mesoblast allogeneic cell therapyNEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited ...

Compared with a contemporary zotarolimus drug-eluting stent, a coronary bioadaptor system is noninferior among patients with CAD receiving PCI.

People with heart disease — and more specifically, heart failure — are extremely vulnerable to air pollution-induced ...